Review




Structured Review

Toray Industries 3d-gene mirna microarray platform
3d Gene Mirna Microarray Platform, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/3d+gene+scanner/pm39069624-56-46-50
Average 90 stars, based on 1 article reviews
3d-gene mirna microarray platform - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Clinical Proteomics:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

Microarray:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

Control:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

Diagnostic Assay:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

Expressing:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

Biomarker Discovery:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

RNA Sequencing:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

Isolation:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.

Derivative Assay:

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Article Snippet: Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [ , , , ].

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsa-miR-4787-3p) diagnostic model [ ] was designed utilizing four microarray datasets with a standardized platform (3D-Gene ® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma.
Article Snippet: A volume of 400 μl of plasma was used as the common denominator in each microarray analysis because the plasma miRNA analyses had no definite internal control, as shown in our previous studies [29–36]. miRNA microarray analysis Microarray analyses of urine samples were performed using the 3D-Gene miRNA microarray platform (Toray Industries, Kamakura, Japan) [32, 34, 37, 38].

Article Title: Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Article Snippet: The microarray analysis of plasma samples was performed using the 3D–Gene miRNA microarray platform (TORAY Industries, Kamakura, Japan).

Article Title: Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Article Snippet: The 3D- Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples.32,33 We compared pre- treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table S2).

Article Title: Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Article Snippet: A serum four microRNA-based (hsa-miR-5100, hsa-miR-1343-3p, hsa-miR-1290, hsamiR-4787-3p) diagnostic model [111] was designed utilizing four microarray datasets with a standardized platform (3D-Gene® Human miRNA Oligo Chip, Toray Industries, Tokyo, Japan).

Article Title: Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
Article Snippet: The 3D‐Gene miRNA microarray platform (Toray Industries) was used to perform microarray analyses of the plasma samples., We compared pre‐treatment plasma miRNA levels between three different ESCC patients with a low response (grade 0 or 1a) to FP therapy and three different ESCC patients with a highly effective response (grade 1b, 2 or 3; Table ).

Article Title: Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Article Snippet: Total RNA isolated from EVs derived from NFs and CAFs was used for miRNA microarray analyses, which were performed using the 3D- Gene miRNA Microarray Platform (Toray Industries), which is designed to contain all miRNAs in miRBase Release 22.



Similar Products

90
Agilent technologies mirna microarray platform
Mirna Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/pmc10913659-30-18-17
Average 90 stars, based on 1 article reviews
mirna microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Toray Industries 3d-gene mirna microarray platform
3d Gene Mirna Microarray Platform, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/3d+gene+scanner/pm39069624-56-46-50
Average 90 stars, based on 1 article reviews
3d-gene mirna microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Agilent technologies human mirna microarray platform
Human Mirna Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/pm37995394-86-8-12
Average 90 stars, based on 1 article reviews
human mirna microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Toray Industries 3d-gene human mirna v21_1.0.0 microarray platform
3d Gene Human Mirna V21 1.0.0 Microarray Platform, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/3d+gene+scanner/pm37935712-342-7-11
Average 90 stars, based on 1 article reviews
3d-gene human mirna v21_1.0.0 microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Thermo Fisher ncode multi-species mirna v.2 microarray platform
Ncode Multi Species Mirna V.2 Microarray Platform, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/pm37906621-64-42-49
Average 90 stars, based on 1 article reviews
ncode multi-species mirna v.2 microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Toray Industries 3d- gene mirna microarray platform
3d Gene Mirna Microarray Platform, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/3d+gene+scanner/pm37190912-33-1-6
Average 90 stars, based on 1 article reviews
3d- gene mirna microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Toray Industries 3d–gene mirna microarray platform
3d–Gene Mirna Microarray Platform, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/3d+gene+scanner/pm37510319-44-10-14
Average 90 stars, based on 1 article reviews
3d–gene mirna microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Thermo Fisher mirna 4.1 array plate microarray platform
Summary of the different types of RNA that can act as a biomarker in liquid biopsy in HNC.
Mirna 4.1 Array Plate Microarray Platform, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/pmc10377854-23-9-8
Average 90 stars, based on 1 article reviews
mirna 4.1 array plate microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
LC Sciences gpl20717 μparaflo tm mirna microarray platform
Summary of the different types of RNA that can act as a biomarker in liquid biopsy in HNC.
Gpl20717 μparaflo Tm Mirna Microarray Platform, supplied by LC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+platform/gpl20717+%CE%BCparaflo+tm+mirna+microarray+platform/10__31557_slash_apjcp__2023__24__6__2043-57-6-12
Average 90 stars, based on 1 article reviews
gpl20717 μparaflo tm mirna microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Cells

Article Title: RNA-Based Liquid Biopsy in Head and Neck Cancer

doi: 10.3390/cells12141916

Figure Lengend Snippet: Summary of the different types of RNA that can act as a biomarker in liquid biopsy in HNC.

Article Snippet: snoRNA , 8 , OSCC , Plasma/Tissue , Affymetrix miRNA 4.1 Array Plate microarray platform , 16 deregulated snoRNAs (1 overexpressed and 15 underexpressed, fold change above 2.01, p < 0.05) , [ ] .

Techniques: Biomarker Assay, Western Blot, Expressing, Binding Assay, Variant Assay, Over Expression, RNA Sequencing Assay, Microarray